You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 20, 2024

Claims for Patent: 4,301,146

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 4,301,146

Title:	Stabilization of 16-oxygenated prostanoic acid derivatives
Abstract:	A stable solid dosage form of the compound .+-.methyl(7-[3(.alpha.)-hydroxy-2-.beta.-(4(RS)-4-hydroxy-4-methyl-trans- 1-octen-1-yl)-oxycyclopent-1.alpha.-yl]heptanoate, said solid dosage form comprising from about 50 to about 500 parts of a polymer selected from the group consisting of hydroxypropylmethyl cellulose and polyvinylpyrolidone per part of said compound.
Inventor(s):	Sanvordeker; Dilip R. (Elk Grove Village, IL)
Assignee:	G. D. Searle & Co. (Skokie, IL)
Application Number:	06/173,292
Patent Claims:	1. A stable solid dispersion of the compound .+-.methyl(7-[3(.alpha.)-hydroxy-2-.beta.-(4(RS)-4-hydroxy-4-methyl-trans- 1-octen-1-yl)-oxycyclopent-1.alpha.-yl]heptanoate, said solid dispersion comprising from about 50 to about 500 parts of a polymer selected from the group consisting of hydroxypropylmethyl cellulose and polyvinylpyrolidone per part of said compound. 2. A dispersion of claim 1 additionally comprising a filler selected from the group consisting of microcrystalline cellulose, mannitol and lactose. 3. A dispersion of claim 2 wherein up to 1000 parts of filler per part of drug is employed. 4. A solid dispersion of claim 1 wherein said polymer is hydroxypropylmethyl cellulose. 5. A solid dispersion of claim 2 or 4 wherein said polymer is hydroxypropylmethyl cellulose and said filler is microcrystalline cellulose. 6. a solid dispersion of claim 2 or 4 wherein said polymer is hydroxypropylmethyl cellulose and said filler is mannitol. 7. A solid dosage form of claim 1 or 2 wherein said polymer is polyvinylpyrrolidone. 8. A solid dispersion of claim 2 or 4 wherein said polymer is polyvinylpropylene and said filler is microcrystalline cellulose. 9. A solid dispersion of claim 2 or 4 wherein said polymer is polyvinylpyrrolidone and said filler is mannitol. 10. A stable solid dosage form of the compound .+-.methyl-(7-[3(.alpha.)-hydroxy-2.beta.-(4(RS)-4-hydroxy-4-methyl-trans- 1-octen-1-yl)oxycyclopent-1.alpha.-yl]hept-4-cis-enoate, said solid dosage form comprising from about 50 to about 500 parts of a polymer selected from the group consisting of hydroxypropylmethyl cellulose and polyvinylpyrrolidone per part of said compound. 11. A dosage form of claim 10 additionally comprising a filler selected from the group consisting of microcrystalline cellulose, mannitol and lactose. 12. A dosage form of claim 11 wherein up to 1000 parts of filler per part of drug is employed. 13. A solid dosage form of claim 10 wherein said polymer is hydroxypropylmethyl cellulose. 14. A solid dosage form of claim 11 or 13 wherein said polymer is hydroxypropylmethyl cellulose and said filler is microcrystalline cellulose. 15. A solid dosage form of claim 11 or 13 wherein said polymer is hydroxypropylmethyl cellulose and said filler is mannitol. 16. A solid dosage form of claim 10 or 11 wherein said polymer is polyvinylpyrrolidone. 17. A solid dosage form of claim 11 or 13 or wherein said polymer is polyvinylpyrrolidone and said filler is microcrystalline cellulose. 18. A solid dosage form of claim 11 or 13 wherein said polymer is polyvinylpyrrolidone and said filler is mannitol. 19. A solid dosage form of claim 11 or 13 wherein said polymer is polyvinylpyrrolidone and said filler is lactose. 20. A solid dosage form of claim 11 or 13 wherein said polymer is hydroxypropylmethyl cellulose and said filler is lactose. 21. A solid dosage form of claim 2 or 4 wherein said polymer is hydroxypropylmethyl cellulose and said filler is lactose. 22. A solid dosage form of claim 2 or 4 wherein said polymer is polyvinylpyrrolidine and said filler is lactose.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.